al have shown that immune checkpoints, such as CTLA-4 and PD-1, when expressed, were correlated with survival rates in patients with resectable GC [43], and various other with PD-L1 (+) expression have been reported to have poor prognoses [44, 45]. This evidence concerns the gene CTLA4 and gastric cancer.